Artios
Artios is pioneering next-generation approaches in the DNA damage response (DDR) field through its comprehensive anti-cancer approach and the deep experience of its team of DDR drug developers.
Artios has raised €258M across 3 funding rounds from 24 investors, most recently a Series D+ round in Nov 2025. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKwww.artiospharma.com ↗
Total raised
€258M
€258,228,066
Funding rounds
3
Investors
24
distinct backers
Active since
2016-09
latest 2025-11
Funding by year
EUR raised per yearArtios — funding by year — interactive chart.
Data table
| Artios — funding by year | |
|---|---|
| 2016 | €29M |
| 2021 | €130M |
| 2025 | €99M |
Signals
High confidenceRaise-next likelihood62
base rate 53% for Series D+
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood25
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 10y since founding (typical exit age)
- ▲ Recent equity round, but funding momentum is down (may be rescue financing)
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-11-17 | Series D+ | €99M | Andera Partners,Avidity Partners,EQT Life Sciences,Invus,IP Group PLC,Janus Henderson Investors+9 more | View deal → |
| 2021-07-27 | Series C | €130M | Avidity Partners,CaaS Capital Management,Deep Track Capital,Invus,Omega Funds,Piper Heartland Healthcare Capital+6 more | View deal → |
| 2016-09-01 | Series A | €29M | Abbvie Biotech Ventures,Imperial Innovations Limited,SV Life Sciences | View deal → |
Investors
24Abbvie Biotech VenturesAndera PartnersAvidity PartnersCaaS Capital ManagementDeep Track CapitalEQT Life SciencesImperial Innovations LimitedInvusIP Group PLCJanus Henderson InvestorsM VenturesNovartis Venture FundOmega FundsPfizer VenturesPiper Heartland Healthcare CapitalRA Capital ManagementRTW Investments LPSchroders CapitalSofinnova PartnersSoleus CapitalSV Health InvestorsSV Life SciencesTCG XTetragon Financial Group Limited
Related news
Similar companies
same sector or countryGlobal coverage: FundingData